D1000 Varejo Farma ParticipacoesBSP:DMVF3 -1.02%79 Return-on-Tangible-Equity is 1.93% as of Mar. 2026, which is 69% below its 10-year median of 6.14. GuruFocus rates BSP:DMVF3 with a GF Score™ of 79/100 and a GF Value™ of R$8.13 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 582 Healthcare Providers & Services companies, D1000 Varejo Farma Participacoes ranks worse than 55.5% on this metric.
The historical rank and industry rank for D1000 Varejo Farma Participacoes's Return-on-Tangible-Equity or its related term are showing as below:
BSP:DMVF3'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 0.39 Med: 6.14 Max: 9.22
Current: 7.87
During the past 9 years, D1000 Varejo Farma Participacoes's highest Return-on-Tangible-Equity was 9.22%. The lowest was 0.39%. And the median was 6.14%.
BSP:DMVF3's Return-on-Tangible-Equity is ranked worse than 55.5% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs BSP:DMVF3: 7.87
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
D1000 Varejo Farma Participacoes Return-on-Tangible-Equity Related Terms
D1000 Varejo Farma Participacoes Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, D1000 Varejo Farma Participacoes's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
D1000 Varejo Farma Participacoes Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, D1000 Varejo Farma Participacoes's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where D1000 Varejo Farma Participacoes's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 1.93% mean?
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a Return-on-Tangible-Equity of 1.93% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on D1000 Varejo Farma Participacoes and its competitors. This is 69% below median its historical median of 6.14. Over the past decade, D1000 Varejo Farma Participacoes' Return-on-Tangible-Equity has ranged from 0.39 to 9.22. According to the industry distribution chart, D1000 Varejo Farma Participacoes ranks #323 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 55.5%.
Is D1000 Varejo Farma Participacoes' Return-on-Tangible-Equity too high?
D1000 Varejo Farma Participacoes' current Return-on-Tangible-Equity of 1.93% is 69% below median its 10-year median of 6.14. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 9.22. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. D1000 Varejo Farma Participacoes' value of 1.93% is 80.8% below this industry median. Based on the distribution chart, D1000 Varejo Farma Participacoes ranks #323 out of 582 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, D1000 Varejo Farma Participacoes ranks #323 out of 582 companies for Return-on-Tangible-Equity. This places D1000 Varejo Farma Participacoes in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.07. D1000 Varejo Farma Participacoes' value of 1.93% is 80.8% below this benchmark. Historically, D1000 Varejo Farma Participacoes' own Return-on-Tangible-Equity has ranged from 0.39 to 9.22 over the past decade. While the company's 10-year median is 6.14 vs. the industry median of 10.07, D1000 Varejo Farma Participacoes has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. D1000 Varejo Farma Participacoes's current Return-on-Tangible-Equity of 1.93% is 80.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on D1000 Varejo Farma Participacoes and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. D1000 Varejo Farma Participacoes's current Return-on-Tangible-Equity is 1.93%, which is 69% below median its own 10-year median of 6.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.13, compared to a current price of R$6.80 — trading 16.4% below its estimated fair value. The current Return-on-Tangible-Equity is 1.93%, which is 69% below median its 10-year median of 6.14 and 80.8% below the Healthcare Providers & Services industry median of 10.07. D1000 Varejo Farma Participacoes' overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current Return-on-Tangible-Equity is 1.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued.
The current stock price of R$6.80 is trading 16.4% below its estimated GF Value™ of R$8.13.
GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.
Key valuation signals for BSP:DMVF3:
Return-on-Tangible-Equity: 1.93% (69% below median its 10-year median of 6.14)
GF Value™: R$8.13 vs. price of R$6.80 (16.4% below fair value)
Industry Position: 80.8% below the Healthcare Providers & Services median (#323 of 582)
No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
D1000 Varejo Farma Participacoes Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DMVF3 has been successfully added to your 
